Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2605541 vs Insulin Glargine in Type 1 Diabetes
NCT01049412Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2010
- Primary completion
- Dec 2010
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of insulin peglispro in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Started Jan 2010; status: completed.
02
Drugs
insulin peglispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01049412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01049412.